Cosmetic Labeling &
Ingredient Review
Cosmetic labeling and ingredient review is a regulatory pre-market check that verifies every element of a cosmetic product label — statement of identity, net quantity, ingredient declaration, responsible person, and warning statements — against U.S. Food and Drug Administration (FDA) requirements. The governing rules are the Federal Food, Drug, and Cosmetic Act (FD&C Act), the labeling regulations in 21 CFR Parts 701 and 740, and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The review confirms INCI names are correct and ordered by predominance, claims do not cross into drug territory, and the responsible person and U.S. address are properly disclosed. Skipping the review exposes a brand to misbranding determinations under 21 U.S.C. 362, FDA warning letters, retailer delisting, import refusal, and mandatory recalls — costs that dwarf the price of getting the label right before launch.
Cosmetic products sold in the United States must comply with FDA labeling and ingredient regulations under federal law and MoCRA. FDA Registration Assistance reviews your labels and ingredient declarations — identifying compliance gaps before your product reaches the market.
What Is FDA Cosmetic Labeling Compliance & Who Must Comply?
The U.S. Food and Drug Administration (FDA) regulates cosmetic labeling under the Federal Food, Drug, and Cosmetic Act and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Every cosmetic product marketed in the United States must carry accurate, complete labeling — including proper ingredient declarations, responsible person information, net quantity statements, and required warning statements.
Non-compliant cosmetic labels can result in FDA enforcement action, misbranding determinations, retailer rejection, or mandatory relabeling. FDA Registration Assistance reviews your labels and ingredient lists to identify compliance gaps before your product reaches the U.S. market.
- All cosmetic products marketed in the U.S. must comply with FDA labeling rules
- Ingredient declarations must use correct INCI names in order of predominance
- Principal Display Panel must include product identity and net quantity
- Responsible person information required under MoCRA
- Warning and caution statements required for applicable products
- Claims must be reviewed for misbranding and drug claim risk
Our Cosmetic Labeling & Ingredient Review Services
Professional label and ingredient compliance reviews — clear, actionable guidance to meet FDA and MoCRA labeling requirements.
Cosmetic Label Compliance Review
We review your full cosmetic label for FDA compliance — including Principal Display Panel layout, product identity, net quantity, responsible person information, warning statements, and label formatting requirements under federal law and MoCRA.
Ingredient Declaration Review
INCI name correctness, proper order by predominance, identification of restricted or prohibited ingredients, and compliance with FDA and MoCRA requirements.
Claims Risk Assessment
We review marketing copy, label claims, and online descriptions to identify statements that may raise misbranding concerns or imply drug use, with compliant alternatives.
Written Compliance Report
A written compliance report detailing identified issues, required corrections, and MoCRA-aligned recommendations.
Trusted MoCRA & Cosmetic Compliance Specialists
Helping domestic and foreign cosmetic companies achieve full MoCRA compliance — accurately and on time.
How Our Cosmetic Label Review Service Works
A straightforward four-step process — submit your label and ingredients, we review, and deliver a clear written report.
Submit Your Label & Ingredients
Provide your cosmetic product label artwork and ingredient list.
Label & Ingredient Review
Our specialists review your label for FDA labeling compliance.
Compliance Issues Identified
We identify all compliance gaps and flag restricted ingredients.
Written Report Delivered
You receive a written compliance report with required corrections.
What a Compliant Cosmetic Label & Responsible Person Must Do
Under the FD&C Act and MoCRA, the responsible person and the label must fulfill specific, legally enforceable duties for every cosmetic distributed in the United States.
Identify the Responsible Person
Display the manufacturer, packer, or distributor name on the label per 21 U.S.C. 364(4), with a U.S. domestic address, phone, or electronic contact (21 U.S.C. 364a(d)).
Declare Ingredients by INCI Name
List every ingredient using FDA-recognized INCI nomenclature in descending order of predominance, with permitted exceptions for ≤1% ingredients and color additives (21 CFR 701.3).
Build a Compliant Principal Display Panel
Place product identity and accurate net quantity on the PDP, in the required type sizes and placement under 21 CFR 701.10, 701.11, and 701.13.
Include Required Warning Statements
Apply mandatory caution language for aerosols, coal-tar hair dyes, feminine deodorants, foaming detergent baths, and suntanning products per 21 CFR Part 740.
Avoid Drug & Misleading Claims
Ensure no on-label, online, or marketing claim implies treatment, cure, or alteration of body structure/function — which would reclassify the product as a drug under 21 U.S.C. 321(g).
Substantiate Product Safety
Maintain records adequately substantiating the safety of the cosmetic product and each ingredient, as required by section 605 of the FD&C Act added by MoCRA.
Register Facility & List Product
Ensure each manufacturing/processing facility is registered with FDA (renewed biennially) and every cosmetic product is listed in Cosmetics Direct, with annual updates.
Report Serious Adverse Events
Submit serious adverse event reports to FDA within 15 business days, accompanied by a copy of the product label, per 21 U.S.C. 364a.
Cosmetic Label & Ingredient Review vs MoCRA Product Listing
These two services are routinely confused — but they are separate regulatory steps. A compliant label is the input; the MoCRA product listing is the FDA submission.
| Cosmetic Label & Ingredient Review | MoCRA Product Listing | |
|---|---|---|
| Who Designates It | Brand or responsible person commissions the review (private regulatory service) | Mandated by FDA — submitted by the responsible person to FDA |
| Who It Represents | An advisory check on behalf of the brand against FDA rules | An official disclosure to FDA identifying each marketed cosmetic product |
| Required By | Industry best practice and legal risk management — not a direct FDA filing | Federal law — Modernization of Cosmetics Regulation Act (MoCRA), 2022 |
| Governing Regulation | FD&C Act §§ 601–602; 21 CFR Parts 701 & 740 | FD&C Act § 607 (added by MoCRA); FDA Form 5067 via Cosmetics Direct |
| Primary Function | Verify the physical label and ingredient declaration are compliant before launch | Tell FDA which cosmetic products you market, who is responsible, and what is in them |
| Required For | Every cosmetic launch, reformulation, or major packaging change | Every cosmetic product distributed in the U.S., with annual updates |
Cosmetic Label & Ingredient Review and MoCRA Product Listing are not interchangeable. The label review is a compliance audit of the product's physical label, ingredient declaration, and claims against the FD&C Act and 21 CFR Parts 701 and 740. The MoCRA Product Listing is a separate federal filing — required by law — in which the responsible person submits each cosmetic product, including its ingredients, to FDA through Cosmetics Direct. The two work in sequence: brands first verify the label is compliant, then submit the listing so FDA's records align with what appears on the package. Most companies need both — the review prevents misbranding before launch, and the listing satisfies MoCRA's mandatory registration regime.
Reviewing Your Cosmetic Label Yourself vs Using a Professional Service
FDA does not pre-approve cosmetic labels — the responsibility is entirely yours. Here is what changes when a specialist handles the review.
| DIY — In-House Review | FDA Registration Assistance | |
|---|---|---|
| Cost | "Free" — paid in staff time, legal exposure, and rework | $249 USD flat fee per label — no surprises |
| Availability | Whenever internal staff have bandwidth | Typically reviewed within a few business days; rush available |
| Domain-Specific Support | General marketing or graphic-design background; limited FDA expertise | Specialists current on FD&C Act, 21 CFR 701/740, and MoCRA |
| Risk of Failure | High — INCI errors, missing warnings, accidental drug claims, restricted ingredients overlooked | Low — systematic check against every applicable FDA requirement |
| Confirmation / Handling | Internal sign-off only; no documented compliance trail | Written compliance report with required corrections and citations |
| Renewal / Update Tracking | Easy to forget when formulas, claims, or packaging change | Re-review available for reformulations, new claims, or packaging updates |
A label that looks compliant often is not. INCI naming, ingredient ordering, type-size rules, mandatory warning placement, and the line between cosmetic and drug claims are all enforced — and FDA only inspects after the product is on the market. Most brands choose a dedicated professional service because the $249 flat fee is dramatically lower than the cost of relabeling inventory, losing an Amazon listing, or receiving an FDA warning letter. A written third-party compliance report also strengthens your defense if regulators or retailers raise questions later.
"Friend Reviewed It" vs FDA Registration Assistance
Many founders rely on a friend, a chemist contact, or a generic online checklist to validate their cosmetic label. Here is the honest comparison.
| Friend / Free Online Checklist | FDA Registration Assistance | |
|---|---|---|
| Government Fee | $0 — FDA charges no fee for label compliance | $0 government fee — $249 USD professional service fee per label |
| Pros | No out-of-pocket cost; quick turnaround if the contact is available | Specialist review, INCI verification, written report, MoCRA-aligned guidance, ongoing support |
| Cons | No FDA-specific expertise; no accountability; no documented audit trail; missed warnings and drug claims are common | Professional service fee — but typically lower than the cost of one mislabeled production run |
| Best For | Initial brainstorming or rough-draft sanity checks only | Any cosmetic product going to market — domestic or imported, online or retail |
There is no FDA fee for cosmetic label review — but "free" rarely means risk-free. An informal review by a friend or a generic checklist routinely misses MoCRA's responsible-person requirements, mandatory 21 CFR Part 740 warnings, ingredient ordering errors, and language that quietly reclassifies a cosmetic as an unapproved drug. The $249 professional fee buys a documented compliance review against current FDA rules — and a paper trail you can show retailers, regulators, and insurers.
Cosmetic Labeling & Ingredient Terms You Should Know
Key technical and regulatory terms used throughout FDA cosmetic labeling and MoCRA compliance.
The Federal Food, Drug, and Cosmetic Act of 1938 — the foundational U.S. statute regulating cosmetics, codified at 21 U.S.C. Chapter 9.
The Modernization of Cosmetics Regulation Act of 2022 — the most significant expansion of FDA cosmetic authority since 1938.
The manufacturer, packer, or distributor whose name appears on the cosmetic product label (21 U.S.C. 364(4)) and who is legally accountable for safety, labeling, and FDA submissions.
International Nomenclature of Cosmetic Ingredients — the standardized ingredient names FDA recognizes on cosmetic labels under 21 CFR 701.3(c).
The portion of the cosmetic label most likely to be displayed at retail — required to bear the statement of identity and net quantity (21 CFR 701.10).
The product's name or descriptive identifier (e.g., "facial moisturizer") that must appear on the PDP under 21 CFR 701.11.
The accurate statement of weight, measure, or count required in the bottom 30% of the PDP under 21 CFR 701.13.
A legal status under 21 U.S.C. 362 where a cosmetic's labeling is false, misleading, or missing required information — triggering FDA enforcement.
A legal status under 21 U.S.C. 361 where a cosmetic contains poisonous, deleterious, filthy, or unsafe substances, or is produced under insanitary conditions.
A claim implying a product treats, cures, prevents, or alters body structure or function — reclassifying a cosmetic as a drug under 21 U.S.C. 321(g).
Any dye, pigment, or substance imparting color to a cosmetic — many of which require FDA pre-approval and certification under 21 CFR Parts 73, 74, and 82.
FDA's electronic submission portal used by responsible persons to file cosmetic facility registrations and product listings under MoCRA.
Why Cosmetic Labels Fail FDA Compliance
The most frequent label and ingredient errors that lead to misbranding determinations, retailer rejections, and FDA enforcement.
Incorrect or Non-INCI Ingredient Names
Common names ("Vitamin E," "shea butter") used instead of FDA-recognized INCI names ("Tocopherol," "Butyrospermum Parkii Butter") trigger misbranding under 21 CFR 701.3(c).
Ingredients in the Wrong Order
Ingredients above 1% must be listed in descending order of predominance; alphabetical or marketing-priority order is a direct violation of 21 CFR 701.3(f).
Drug Claims on Cosmetic Labels
Language like "heals," "treats acne," or "regenerates cells" reclassifies the product as an unapproved drug under 21 U.S.C. 321(g) — exposing the brand to import refusal and warning letters.
Missing or Improper Responsible Person Info
No U.S. domestic address, phone, or electronic contact on the label violates 21 U.S.C. 364a(d) — a hard fail under MoCRA that blocks adverse event reporting compliance.
Restricted or Prohibited Ingredients
Substances banned under 21 CFR Part 700 — mercury compounds, chloroform, methylene chloride, hexachlorophene above limits — render the product adulterated under 21 U.S.C. 361.
Missing Mandatory Warning Statements
Aerosol cosmetics, coal-tar hair dyes, foaming detergent baths, and suntanning preparations require specific warnings under 21 CFR Part 740. Omitting them is automatic misbranding.
Net Quantity Errors
Wrong units, missing dual metric/avoirdupois declaration, or placement outside the bottom 30% of the PDP violates 21 CFR 701.13.
Label Inconsistent With MoCRA Listing
Different ingredient lists or responsible persons between the physical label and the FDA Cosmetics Direct submission cause listing rejections and compliance reviews.
Complete MoCRA & Cosmetic Compliance Solutions
From facility registration and product listing to labeling review, U.S. Agent services, and state-level reporting.
MoCRA Facility Registration
Register your domestic or foreign cosmetic facility with the FDA under MoCRA.
MoCRA Product Listing
List all cosmetic products you manufacture or process for the U.S. market using FDA Form 5067.
U.S. Agent Services
Foreign cosmetic facilities must designate a U.S. Agent — we serve as your FDA-authorized U.S. Agent.
Cosmetic Labeling & Ingredient Review
Ingredient declarations, warnings, and net contents reviewed by specialists.
California Safe Cosmetics Act (CSCAR)
Report cosmetic ingredients linked to cancer or reproductive harm to the California Safe Cosmetics Program.
DUNS Number Assistance
Obtain the DUNS number required to complete your FDA cosmetic facility registration.
MoCRA Listing Certificate
Official certificate as proof of your FDA cosmetic facility registration and product listing.
MoCRA Annual Renewals
We track your renewal deadline and handle the full annual renewal submission on your behalf.
Frequently Asked Questions — Cosmetic Labeling & Ingredient Review
Common questions about FDA cosmetic labeling, ingredient declarations, INCI names, claims compliance, and MoCRA labeling obligations.
Are cosmetic products required to follow FDA labeling rules?
Yes. All cosmetic products marketed in the United States must comply with FDA labeling requirements under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Labels must include the product identity, net quantity, responsible person information, ingredient declaration, and any required warning statements. Non-compliant labels may be considered misbranded and subject to FDA enforcement action.
What is required on a cosmetic label under FDA regulations?
FDA cosmetic labeling requirements include: a statement of identity (product name and type), net quantity of contents, responsible person name and address, complete ingredient declaration using INCI names in descending order of predominance, and any required warning or caution statements. MoCRA requires the responsible person to be identified on the label.
What are INCI names and why are they required?
INCI (International Nomenclature of Cosmetic Ingredients) names are standardized ingredient names adopted by the FDA for cosmetic ingredient declarations under 21 CFR 701.3. Using correct INCI names is required by FDA regulations. Incorrect names may result in a misbranding determination.
Does the FDA approve cosmetic labels before a product is sold?
No. The FDA does not pre-approve cosmetic labels or formulations before a product is marketed. Cosmetic companies are responsible for ensuring their products and labels comply with all applicable FDA regulations before marketing.
What is the Principal Display Panel (PDP) for cosmetics?
The Principal Display Panel is the portion of the cosmetic label most likely to be seen by the consumer at the point of purchase. FDA regulations at 21 CFR 701.10 and 701.11 require the PDP to include the product identity statement and the net quantity of contents.
What claims can I make on a cosmetic label?
Cosmetic claims must describe the product's effect on the appearance of the body without implying that the product affects the structure or function of the body. Claims that suggest a drug effect — such as treating, curing, or preventing a condition — may cause the FDA to classify the product as a drug rather than a cosmetic.
Does MoCRA change cosmetic labeling requirements?
Yes. MoCRA expands FDA oversight of cosmetics and increases the importance of accurate labeling. Under MoCRA, the responsible person must be clearly identified on the label, and product listings submitted to the FDA must align with the labeling. MoCRA also gives the FDA broader authority — including mandatory recall authority.
What happens if my cosmetic label is non-compliant?
Non-compliant cosmetic labels may be considered misbranded under section 602 of the FD&C Act (21 U.S.C. 362). Consequences can include FDA warning letters, mandatory product relabeling, retailer rejection or delisting, import refusal for foreign products, and potential product recalls.
Can FDA Registration Assistance review my existing cosmetic labels?
Yes. We review both new product labels before launch and existing cosmetic labels already in the market. Whether you are launching a new product, reformulating, updating packaging, or entering the U.S. market for the first time, our label and ingredient review ensures compliance.
What does the ingredient review cover?
Our ingredient review covers INCI name accuracy, correct ordering by predominance under 21 CFR 701.3, identification of any restricted or prohibited ingredients under 21 CFR Part 700, and alignment with your MoCRA product listing ingredient declaration.
Are there ingredients restricted or prohibited in U.S. cosmetics?
Yes. The FDA prohibits or restricts ingredients under 21 CFR Part 700, including bithionol, chloroform, hexachlorophene, mercury compounds (except limited eye-area preservative use), methylene chloride, vinyl chloride and zirconium in aerosols, and prohibited cattle materials.
Does cosmetic labeling compliance apply to foreign manufacturers?
Yes. All cosmetic products marketed in the United States must comply with FDA labeling requirements regardless of where they are manufactured. Foreign manufacturers must include correct INCI declarations, English-language labeling, proper responsible person identification with a U.S. address, and required warning statements.
What is a responsible person under MoCRA?
Under section 604(4) of the FD&C Act (added by MoCRA), the responsible person is the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label. The responsible person is accountable for product safety, accurate labeling, MoCRA facility registration, product listing, safety substantiation, and serious adverse event reporting.
Does label review include online and marketing claims?
Yes. We can review online product descriptions, marketing copy, and social media claims in addition to physical label text. Claims made anywhere about a cosmetic product can affect the product's regulatory classification under the FD&C Act.
How long does the cosmetic label review take?
Most reviews are completed within a few business days of receiving your complete label artwork and full formulation information. Rush reviews can be accommodated where needed.
What information do I need to submit for a label review?
Please provide your complete label artwork or label text, your full ingredient list with INCI names and concentrations if available, and any claims or marketing copy you would like reviewed.
How much does cosmetic labeling and ingredient review cost?
Cosmetic Labeling & Ingredient Review is $249 USD per label — a one-time flat fee, not a subscription. The fee covers the full FDA and MoCRA compliance review of one cosmetic product label, including INCI ingredient declaration verification, Principal Display Panel layout, responsible person and net quantity check, mandatory warning statement review under 21 CFR Part 740, claims risk assessment, and a written compliance report. Brands launching multiple products often pair this with our MoCRA Product Listing — billed separately.
Can a friend or unrelated party act as the responsible person?
Technically yes, but it is strongly discouraged. Under section 604(4) of the FD&C Act, a friend or unrelated party who agrees to be named takes on legal accountability for the product — including MoCRA facility registration, product listing, safety substantiation records, serious adverse event reporting within 15 business days, and exposure to FDA enforcement, mandatory recalls, and import refusals.
What happens if the responsible person doesn't respond?
Serious legal and commercial consequences. The responsible person must receive adverse event reports through the domestic address, phone, or electronic contact on the label (21 U.S.C. 364a(d)) and submit serious adverse event reports to FDA within 15 business days. Failure to respond can result in misbranding determinations, facility registration suspension under MoCRA, import refusal, retailer delisting, mandatory recalls, and warning letters.
How do I change the responsible person on an existing registration?
Changing the responsible person requires (1) reprinting all product labels with the new responsible person name and U.S. address, (2) updating the MoCRA Cosmetic Product Listing in Cosmetics Direct, and (3) ensuring the new responsible person is registered and prepared to receive adverse event reports. Existing inventory bearing the old label generally must be relabeled or removed from commerce.
Do I need a label review if I only sell on Amazon, Shopify, Etsy, or TikTok Shop?
Yes. FDA cosmetic labeling rules apply to every cosmetic product distributed in U.S. commerce, regardless of sales channel. Amazon, Shopify, Etsy, Walmart Marketplace, and TikTok Shop all require sellers to comply with applicable FDA regulations, and Amazon routinely delists cosmetic listings for missing INCI declarations, drug-like claims, or unverifiable responsible person information.
Does cosmetic label review apply to soap, deodorant, sunscreen, or anti-dandruff shampoo?
It depends on intended use. True soap (alkali salt of fatty acids, sold solely as soap) is regulated by the Consumer Product Safety Commission, not FDA. Antiperspirant deodorants, sunscreens, anti-dandruff shampoos, anti-cavity toothpastes, and acne products are OTC drugs or drug/cosmetic combinations and must follow OTC Drug Facts labeling under 21 CFR 201.66 in addition to cosmetic ingredient rules.
What's the difference between a cosmetic and a "cosmeceutical"?
Legally, there is no such category. The FD&C Act recognizes only cosmetics, drugs, and combination cosmetic/drug products. "Cosmeceutical" is a marketing term with no regulatory meaning. Products marketed as cosmeceuticals that make structure/function or disease-treatment claims are treated by FDA as unapproved new drugs.
Are "natural," "organic," "clean," or "hypoallergenic" claims regulated?
Yes — and the FDA does not define these terms. There is no FDA standard for "natural," "organic," "clean," "non-toxic," or "hypoallergenic" on cosmetic labels, which means such claims must not be false or misleading under section 602(a) of the FD&C Act. "Organic" may additionally be subject to USDA National Organic Program rules.
Does fragrance need to be broken into individual components?
Generally no. Under 21 CFR 701.3, fragrances and flavors may be declared collectively as "Fragrance" or "Flavor" without listing individual components. However, MoCRA requires the responsible person to disclose fragrance ingredients to FDA on request, and FDA is developing fragrance allergen labeling rules.
Do I need a U.S. address on my cosmetic label if I'm based overseas?
Yes. Section 364a(d) of the FD&C Act requires the responsible person to receive adverse event reports through a domestic address, domestic telephone number, or electronic contact on the label. Foreign brands typically resolve this by designating a U.S. Agent or U.S.-based distributor as the responsible person.
How can I verify a cosmetic product is properly registered with FDA?
There is no public lookup tool. FDA does not publish a public database of registered cosmetic facilities or listed products — submissions in Cosmetics Direct are confidential. Compliance can only be verified by reviewing the label itself, requesting documentation from the brand, or having a specialist review the product. There is no FDA "seal of approval" for cosmetics.
Does label review cover sample sizes, travel sizes, or testers?
Yes — labeling rules adjust by package size. 21 CFR 701.3(b) and 21 CFR 701.9 permit smaller letter heights (1/32 inch instead of 1/16 inch) and limited off-package ingredient labeling for packages with surface area less than 12 square inches. "Free sample — not for sale" testers and trial sizes are still cosmetics and must carry the responsible person and ingredient declaration.
Can the same label be used for the U.S. and other countries (EU, UK, Canada)?
Usually not without modification. INCI naming is broadly harmonized, but the U.S. requires a U.S.-domiciled responsible person, English-language declarations, and specific 21 CFR Part 740 warnings. Canada's Cosmetic Regulations and the EU Cosmetic Regulation (EC) 1223/2009 impose different ingredient restrictions and warning text.
What's the difference between "FDA-approved" and "FDA-compliant"?
FDA does not approve cosmetic ingredients (except color additives). Under U.S. law, cosmetic ingredients other than color additives do not require FDA pre-approval — the responsible person is legally accountable for safety and proper labeling. Therefore, no cosmetic label may claim a product is "FDA approved." A compliant label is FDA-compliant, not FDA-approved. We flag any "FDA approved" language as a misbranding risk.
Review Your Cosmetic Labels Today
Submit your cosmetic facility details and our MoCRA compliance specialists will prepare and submit your FDA registration — accurately and on time.
Thank You for Reaching Out!
We've received your message and will get back to you within 24 hours. If you need immediate assistance, please call us directly.